Evidence map›Paper›PMID 41673415›Full record

ArticleScientific reports2026

Enhanced breast cancer detection framework based on YOLOv11n with multi-scale feature calibration.

Ziqiong He, Chen Zhang, Chen Liang, Wenyue Li

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ziqiong HeResearch Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Chen ZhangDepartment of General Surgery, the Second Affiliated Hospital of Fujian Medical University, QuanZhou, 362000, Fujian Province, China.
Chen LiangThe Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China. liangchen212@126.com.
Wenyue LiDepartment of General Surgery, the Second Affiliated Hospital of Fujian Medical University, QuanZhou, 362000, Fujian Province, China. 984187360@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer poses a persistent global health challenge, making early diagnosis indispensable for reducing mortality and improving patient prognosis. However, conventional detection paradigms are frequently impeded by the inherent complexity of lesions, characterized by minute dimensions, morphological heterogeneity, and indistinct boundaries. To address these impediments, this study proposes an advanced detection framework building upon YOLOv11n. We introduce three novel architectural components, specifically the C3k2-DCNv2-Dynamic, C2CGA, and CSFCN modules, designed to synergize feature extraction, fusion, and calibration. The C3k2-DCNv2-Dynamic module employs dynamic convolution and deformable mechanisms to robustly accommodate scale variations. Concurrently, the C2CGA module exploits a channel-guided attention mechanism within a multi-branch topology to heighten sensitivity toward complex lesion regions. Furthermore, the CSFCN module synthesizes contextual and spatial feature calibration to refine the identification of small targets. Extensive empirical evaluations validate the efficacy of the proposed method. The model achieved a precision of 66.6% and a mean Average Precision (mAP@0.5) of 86.2%, surpassing the baseline YOLOv11n by 5.5 and 2.4% points, respectively. Notably, detection accuracy for small G2-class lesions improved by a substantial 14.1% points. These findings substantiate the superior performance of our framework in resolving small and complex lesion detection, suggesting significant potential for clinical deployment.

Indexed as

Breast NeoplasmsAlgorithmsCalibrationDetection AlgorithmsFemaleHumansBreast cancer detectionC2CGA moduleC3k2-DCNv2-Dynamic moduleCSFCN moduleMedical imagingYOLOv11n

Identifiers

PMID41673415
PMCPMC12976260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.